@techinasia.com 9 months ago
Doctor Anywhere’s FY 2022 revenue up 62%, losses widen to $33m
@techcrunch.com 1 year ago
Nanopath is looking to drastically change medical diagnostics
@xconomy.com 3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com 4 years ago
NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up
@xconomy.com 5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com 5 years ago
Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards
@xconomy.com 5 years ago
Health Wildcatters Splits Program in Two, Debuts Latest Startup Class
@xconomy.com 5 years ago
30Ventures Seeks $15M to Fund Startups in Healthcare, Water Tech